Clearside Biomedical Q3 EPS $(0.10) Beats $(0.13) Estimate, Sales $1.04M Beat $122.86K Estimate
Clearside Biomedical Q3 EPS $(0.10) Beats $(0.13) Estimate, Sales $1.04M Beat $122.86K Estimate
clearside biomedical 第三季每股收益为$(0.10)，超出$(0.13)的预期，销售额为104万美元，超出12.286万美元的预期
Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 33.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.04 million which beat the analyst consensus estimate of $122.86 thousand by 744.88 percent. This is a 20.84 percent increase over sales of $859.00 thousand the same period last year.